التفاصيل البيبلوغرافية
| العنوان: |
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor |
| المؤلفون: |
Ogrodniczak, Alicja, Menkiszak, Janusz, Gronwald, Jacek, Tomiczek-Szwiec, Joanna, Szwiec, Marek, Cybulski, Cezary, Dębniak, Tadeusz, Huzarski, Tomasz, Tołoczko-Grabarek, Aleksandra, Byrski, Tomasz, Białkowska, Katarzyna, Prajzendanc, Karolina, Baszuk, Piotr, Lubiński, Jan, Jakubowska, Anna |
| المصدر: |
Hereditary Cancer in Clinical Practice ; volume 20, issue 1 ; ISSN 1897-4287 |
| بيانات النشر: |
Springer Science and Business Media LLC |
| سنة النشر: |
2022 |
| مصطلحات موضوعية: |
Genetics (clinical), Oncology |
| الوصف: |
Background There are several genes associated with ovarian cancer risk. Molecular changes in borderline ovarian tumor (BOT) indicate linkage of this disease to type I ovarian tumors (low-grade ovarian carcinomas). This study determined the prevalence and association of mutations in BRCA1, BRCA2, PALB2, RAD51C , and CHEK2 with the risk of BOTs. Methods The study group consisted of 102 patients with histologically confirmed BOT and 1743 healthy controls. In addition, 167 cases with ovarian cancer G1 were analyzed. The analyses included genotyping of 21 founder and recurrent mutations localized in 5 genes ( BRCA1, BRCA2, PALB2, RAD51C, and CHEK2). The risk for developing BOT and low-grade ovarian cancer, as well as the association of tested mutations with survival, was estimated. Results The CHEK2 missense mutation (c.470T>C) was associated with 2-times increased risk of BOT (OR=2.05, p =0.03), at an earlier age at diagnosis and about 10% worse rate of a 10-year survival. Mutations in BRCA1 and PALB2 were associated with a high risk of ovarian cancer G1 (OR=8.53, p =0.005 and OR=7.03, p =0.03, respectively) and were related to worse all-cause survival for BRCA1 carriers (HR=4.73, 95%CI 1.45–15.43, p =0.01). Conclusions Results suggest that CHEK2 (c.470T>C) may possibly play a role in the pathogenesis of BOT, but due to the low number of BOT patients, obtained results should be considered as preliminary. Larger more in-depth studies are required. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1186/s13053-022-00218-0 |
| DOI: |
10.1186/s13053-022-00218-0.pdf |
| DOI: |
10.1186/s13053-022-00218-0/fulltext.html |
| الإتاحة: |
https://doi.org/10.1186/s13053-022-00218-0Test |
| حقوق: |
https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test |
| رقم الانضمام: |
edsbas.400E54DC |
| قاعدة البيانات: |
BASE |
